CDC launched two global networks, awarded $22 million to combat antimicrobial resistance and infectious diseases
On Dec. 7, 2021, the Centers for Disease Control and Prevention announced that it had awarded $22 million…
-
-
CHMP recommended EU approval of Actemra/RoActemra to treat patients with severe COVID-19
On Dec. 6, 2021, Roche announced that the European Medicines Agencyﾒs Committee for Medicinal Products for Human Use…
-
WHO advised against use of convalescent plasma for covid-19
On Dec. 6, 2021, the World Health Organization Guideline Development Group of international experts announced in the BMJ…
-
USAID announced Initiative for Global Vaccine Access to accelerate vaccine access and delivery around the world
On Dec. 6, 2021, the USAID announced the foundation of a new whole-of-government effort, the Initiative for Global…
-
Johnson & Johnson COVID-19 booster showed substantial increase in antibody and T-cell responses
On Dec. 5, 2021, Johnson & Johnson announced preliminary results from an independent study, including a subset of…
-
Roche announced the launch SARS-CoV-2 & Flu A/B Rapid Antigen Test in countries accepting the CE Mark
On Dec. 5, 2021, Roche announced that its planned to launch the SARS-CoV-2 & Flu A/B Rapid Antigen…
-
Sorrento announced publication of novel SARS-CoV-2 main protease inhibitors for potential treatment of COVID-19 patients infected with SARS-CoV-2
On Dec. 5, 2021, Sorrento Therapeutics announced the peer-reviewed publication of a series of novel SARS-CoV-2 MPro inhibitors…
-
Genomics England sets out vision for newborn genomes research pilot
On Dec. 3, 2021, Genomics England has announced its vision for a pilot research project to examine the…
-
Gavi approved malaria vaccine programme funding
On Dec. 3, 2021, Gavi, the Vaccine Alliance, approved a new malaria vaccination programme to support the introduction,…
-
Roche announced additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant
On Dec. 3, 2021, Roche and TIB Molbiol announced they had added three additional Research Use Only test…
-
HHS study showed 63-fold increase in Medicare Telehealthutilization during the Pandemic
On Dec. 3, 2021, a report from the U.S. Department of Health and Human Services (HHS) found that…
-
Resilience and Harvard University announced five-year R&D alliance to incubate new technologies
On Dec. 2, 2021, National Resilience and Harvard University announed they had established a five-year research and development…
-
NIH scientists discovered new B cell that tempers autoimmunity
On Dec. 2, 2021, researchers at the National Eye Institute (NEI) announced they had identified, isolated, and characterized…
-
Fulgent Genetics confirmed ability to detect Omicron variant with RT-PCR tests for COVID-19
On Dec. 1, 2021, Fulgent Genetics confirmed that the Companyﾒs RT-PCR test for SARS-CoV-2, the virus that causes…
-
SIGA announced Health Canada regulatory approval of Oral TPOXX
On Dec. 1, 2021, SIGA Technologies announced that Health Canada had approved oral TPOXX (tecovirimat) as an extraordinary…
-
First confirmed case of Omicron variant detected in the United States
On Dec. 1, 2021, the California and San Francisco Departments of Public Health confirmed that a recent case…
-
Moderna announced supply agreement with the UK for additional 60 million doses of COVID-19 vaccine in 2022 and 2023
On Dec. 1, 2021, Moderna announced a revised supply agreement with the UK government for up to 60…
-
T2 Biosystems T2SARS-CoV-2 panel detected Omicron variant
On Dec. 1, 2021, T2 Biosystems announced that its T2SARS-CoV-2 Panel detected the Omicron COVID-19 variant (B.1.1.529). The…
-
INOVIO Announced Strategy to Address Omicron (B.1.1.529) and Future SARS-CoV-2 Variants
On Nov. 30, 2021, Inovio Pharma announced the company was rapidly moving to evaluate its COVID-19 DNA vaccine…
-
Labcorp announced collection for COVID-19 PCR testing in over 500 Locations nationwide, with plans to double locations
On Nov. 30, 2021, LabCorp announced that it had begun offering observed self-collection for COVID-19 PCR testing in…
-
Thermo Fisher Scientific confirmed detection of SARS-CoV-2 in samples containing Omicron Variant with TaqPath COVID-19 tests
On Nov. 29, 2021, Thermo Fisher Scientific confirmed that its polymerase chain reaction (PCR) TaqPath COVID-19 Combo Kit…
-
Hologic’s COVID-19 tests detected Omicron variant
On Nov. 29, 2021, Hologic announced that its three SARS-CoV-2 tests all detect the recently emerged Omicron variant of…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | FDA | Infectious Disease | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 roller coaster
The COVID-19 Roller Coaster is a wild ride! Strap yourself in and hold on for the ride of…
-
WHO announced classification of Omicron (B.1.1.529): SARS-CoV-2 variant of concern
On Nov. 26, 2021, the World Health Organization announced that the Technical Advisory Group on SARS-CoV-2 Virus Evolution…
-
Merck and Ridgeback Biotherapeutics provided update on results from MOVe-OUT study of Molnupiravir in adults with COVID-19
On Nov. 26, 2021, Merck provided an update on the MOVe-OUT study of molnupiravir, an investigational oral antiviral…
-
Pfizer and BioNTech received positive CHMP opinion for COMIRNATY in children 5 to under 12 years of age in the EU
On Nov. 25, 2021, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…
-
Johnson & Johnson COVID-19 vaccine fully approved by Health Canada to prevent COVID-19 in ages 18 years and older
On Nov. 24, 2021, Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) had issued Emergency…
-
Novavax filed for interim authorization of COVID-19 vaccine in singapore
On Nov. 24, 2021, Novavax announced its submission to the Singapore Health Sciences Authority for interim authorization of…
-
Oxitec successfully concluded mosquito releases in landmark Florida Keys pilot program
On Nov. 23, 2021, Oxitec announced the successful completion of the mosquito release phase of its landmark project…
-
WHO and Medicines Patent Pool announced first transparent, global, non-exclusive licence for COVID-19 technology
On Nov. 23, 2021, the World Health Organization’s COVID-19 Technology Access Pool and the Medicines Patent Pool finalized…
